Geneva Capital Management LLC Biolife Solutions Inc Transaction History
Geneva Capital Management LLC
- $5.85 Billion
- Q2 2025
A detailed history of Geneva Capital Management LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Geneva Capital Management LLC holds 901,764 shares of BLFS stock, worth $21.7 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
901,764
Previous 852,127
5.83%
Holding current value
$21.7 Million
Previous $19.5 Million
0.2%
% of portfolio
0.33%
Previous 0.37%
Shares
18 transactions
Others Institutions Holding BLFS
# of Institutions
205Shares Held
50.4MCall Options Held
0Put Options Held
0-
Casdin Capital, LLC New York, NY7.71MShares$185 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.25MShares$102 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$86.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$69.7 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.03B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...